Finally, the CF group exhibited decreased gene and protein expression levels of SIRT1, PGC-1α, and NRF1, while all treatments restored the expression levels, which suggests that MSNS can alleviate CF-associated hippocampal mitochondrial dysfunction by increasing the efficiency of mitochondrial biogenesis. This evidence concerns the gene PPARGC1A and cystic fibrosis.